2-异丙氧基苯甲醛 | 22921-58-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-异丙氧基苯甲醛
• 英文名称: 2-isopropoxybenzaldehyde
• 英文别名: o-isopropoxybenzaldehyde；2-iso-propyloxybenzaldehyde；2-propan-2-yloxybenzaldehyde
• CAS: 22921-58-0
• 化学式: C₁₀H₁₂O₂
• mdl: MFCD01571834
• 分子量: 164.204
• InChiKey: ZZJVNPRHHLLANO-UHFFFAOYSA-N

物化性质

• 沸点：
  72-73 °C(Press: 0.3 Torr)
• 密度：
  1.036±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  <p><b></b></p>

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2912499000
• WGK Germany：
  3
• 危险性防范说明：
  P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H315,H319,H335
• 储存条件：
  <p><br></p>

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Isopropoxybenzaldehyde
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Isopropoxybenzaldehyde
CAS number: 22921-58-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H12O2
Molecular weight: 164.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

合成制备方法
用途

反应信息

• 作为反应物：
  描述：

  2-异丙氧基苯甲醛 在 lithium chloride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 22.0h， 以5%的产率得到水杨醛
  参考文献：
  名称：

  Dealkylation of Activated Alkyl Aryl Ethers Using Lithium Chloride in Dimethylformamide

  摘要：

  在邻位或对位含有吸电子取代基的烷基芳基醚，在二甲基甲酰胺中能被氯化锂轻易裂解。

  DOI：

  10.1055/s-1989-27225
• 作为产物：
  描述：

  2-乙氧基苯甲醛 在 吡啶 、 potassium carbonate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 20.0~650.0 ℃ 、4.0 Pa 条件下， 反应 22.0h， 生成 2-异丙氧基苯甲醛
  参考文献：
  名称：

  1-（2-烷氧基苯基）烷胺基的反应

  摘要：

  通过闪蒸真空热解（FVP）在气相中或在溶液中通过标准方法分别生成亚胺基1d和1e可能通过涉及1,6的机理生成1,3-苯并恶嗪18和22。 -氢原子易位。在FVP条件下，2-氰基苯酚14是2-烷氧基苯基烷胺基1b–d的主要产物；脱烷基反应是反应机理不可或缺的部分，而不是随后的2-烷氧基苄腈的反应，而2-烷氧基苄腈本身只是热解的极少产物。

  DOI：

  10.1039/b103181n
• 作为试剂：
  描述：

  1-溴-2-异丙氧基苯 、 3-溴苯基异丙醚 在 2-异丙氧基苯甲醛 、 silica 、 hexane-diethyl ether 作用下， 以afforded the title compound (2.3 g, 70%)的产率得到2-异丙氧基苯甲醛
  参考文献：
  名称：

  Ukokinase inhibitors

  摘要：

  具有以下化学式的化合物是尿激酶抑制剂，并且在治疗尿激酶发挥作用的疾病方面非常有用。还披露了抑制尿激酶的组合物和一种在哺乳动物中抑制尿激酶的方法。

  公开号：

  US06284796B1

文献信息

• [EN] COMPOUNDS FOR THE TREATMENT OF AMYLOID-ASSOCIATED DISEASES<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DE MALADIES ASSOCIÉES À LA SUBSTANCE AMYLOÏDE
  申请人：REMYND NV

  公开号：WO2016083490A1

  公开（公告）日：2016-06-02

  This invention provides novel compounds of formulae (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein the substituents are as defined in the specification. The present invention also relates to the novel compounds for use as a medicine, more in particular for the prevention or treatment of amyloid-related diseases, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, disorders characterized by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such amyloid-related diseases. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.

  这项发明提供了式(I)或(II)或其立体异构体、对映异构体、消旋体或互变异构体的新化合物，其中取代基如规范中所定义。本发明还涉及用作药物的这些新化合物，更具体地用于预防或治疗与淀粉样蛋白相关的疾病，更具体地说是某些神经系统疾病，如被统称为tau病变的疾病，以及由细胞毒性α-突触核蛋白淀粉生成所特征化的疾病。本发明还涉及利用这些新化合物制备对治疗此类淀粉样蛋白相关疾病有用的药物。本发明还涉及包括这些新化合物的药物组合物以及这些新化合物的制备方法。
• Quinolines useful in treating cardiovascular disease
  申请人：Collini D. Michael

  公开号：US20050131014A1

  公开（公告）日：2005-06-16

  This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.

  本发明提供了式I化合物的用途，它们在治疗或抑制LXR介导的疾病中是有用的。
• Substituted Pyrrolidines and Methods of Use
  申请人：AbbVie S.à.r.l.

  公开号：US20180099931A1

  公开（公告）日：2018-04-12

  The invention discloses compounds of Formula (I) wherein R 1 , R 2 , R 2A , R 3 , R 3A , R 4 , R 4A , and R 5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

  该发明公开了式（I）的化合物 其中R 1 ，R 2 ，R 2A ，R 3 ，R 3A ，R 4 ，R 4A 和R 5 如本文所定义。本发明涉及化合物及其在囊性纤维化治疗中的应用，其生产方法，包含相同化合物的药物组合物，以及通过给予该发明的化合物来治疗囊性纤维化的方法。
• Large‐Scale Synthesis of a Niche Olefin Metathesis Catalyst Bearing an Unsymmetrical N‐Heterocyclic Carbene (NHC) Ligand and its Application in a Green Pharmaceutical Context
  作者：Tomasz Nienałtowski、Paweł Szczepanik、Paweł Małecki、Dorota Czajkowska‐Szczykowska、Stefan Czarnocki、Jolanta Pawłowska、Anna Kajetanowicz、Karol Grela

  DOI：10.1002/chem.202003830

  日期：2020.12

  large‐scale synthesis of known Ru olefin metathesis catalyst VII featuring an unsymmetrical N‐heterocyclic carbene (NHC) ligand with one 2,5‐diisopropylphenyl (DIPP) and one thiophenylmethylene N‐substituent is reported. The optimised procedure does not require column chromatography in any step and allows for preparation of up to 0.5 kg batches of the catalyst from simple precursors. The application profile

  据报道大规模合成了已知的钌烯烃复分解催化剂VII，该催化剂具有一个不对称的N-杂环卡宾（NHC）配体，其中有一个2,5-二异丙基苯基（DIPP）和一个硫代苯基亚甲基N取代基。优化的程序在任何步骤都不需要柱色谱，并且可以从简单的前体中制备多达0.5 kg批次的催化剂。在环保型碳酸二甲酯（DMC）中研究了所得催化剂的应用概况。虽然七在与缺乏电子的配偶的交叉复分解（CM）中显示出低效率，对于具有容易使C-C双键异构化的底物，其结果达到了良好至优异的结果。这包括具有药用化学意义的多功能底物，例如精神活性5F‐PB‐22和NM‐2201的类似物以及两种PDE5抑制剂西地那非和伐地那非。最后，在DMC中对Vardenafil衍生物进行了较大规模的闭环复分解（RCM），从而以高收率和低Ru污染水平（7.7 ppm）直接分离了预期的产物（23 g）。
• METHOD FOR PROMOTING PLANT GROWTH
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20150282482A1

  公开（公告）日：2015-10-08

  The present invention provides a method for promoting plant growth, which comprises treating a plant with a compound represented by the following Formula (1): provided that a method for promoting plant growth which comprises treating plants with a compound corresponding to any one of the following (1) to (8) is excluded: (1) Methyl 4-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (2) Methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (3) Methyl 6-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (4) Methyl 7-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (5) Ethyl 4-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (6) Ethyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (7) Ethyl 6-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, and (8) Ethyl 7-(trifluoromethyl)benzo[b]thiophene-2-carboxylate.

  本发明提供了一种促进植物生长的方法，包括用下式表示的化合物处理植物： 只要排除用与以下任一化合物相对应的化合物处理植物的促进植物生长方法：(1) 甲基4-(三氟甲基)苯并[b]噻吩-2-羧酸酯，(2) 甲基5-(三氟甲基)苯并[b]噻吩-2-羧酸酯，(3) 甲基6-(三氟甲基)苯并[b]噻吩-2-羧酸酯，(4) 甲基7-(三氟甲基)苯并[b]噻吩-2-羧酸酯，(5) 乙基4-(三氟甲基)苯并[b]噻吩-2-羧酸酯，(6) 乙基5-(三氟甲基)苯并[b]噻吩-2-羧酸酯，(7) 乙基6-(三氟甲基)苯并[b]噻吩-2-羧酸酯，以及(8) 乙基7-(三氟甲基)苯并[b]噻吩-2-羧酸酯。